ストックスクリーナーアプリを入手
4.65
10.40%
-0.54
アフターアワーズ：
4.66
0.010
+0.22%
前日終値:
$5.19
開ける：
$5.19
24時間の取引高:
235.55K
Relative Volume:
1.50
時価総額：
$49.27M
収益：
$16.03M
当期純損益:
$-18.83M
株価収益率:
-1.3286
EPS:
-3.5
ネットキャッシュフロー:
$-14.87M
1週間 パフォーマンス:
-32.12%
1か月 パフォーマンス:
-19.97%
6か月 パフォーマンス:
-65.53%
1年 パフォーマンス:
-32.12%
1日の値動き範囲:
$4.63
$5.25
1週間の範囲:
$4.63
$7.135
52週間の値動き範囲:
$4.63
$19.49
Electrocore Inc Stock (ECOR) Company Profile
ECOR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
4.65 | 49.27M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-14 | アップグレード | BTIG Research | Neutral → Buy |
| 2019-11-14 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | 再開されました | Cantor Fitzgerald | Neutral |
| 2019-05-30 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-05-09 | 開始されました | Noble Capital Markets | Outperform |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Electrocore Inc (ECOR) 最新ニュース
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions Drive Growth - GuruFocus
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
Bioelectric Medicine Market Rises with Innovation in Neuromodulation Therapies | ElectroCore, Medtronic, Abbott - openPR.com
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
ElectroCore Reports Strong Q1 Growth and Strategic Expansion - TipRanks
Earnings call transcript: ElectroCore’s Q1 2025 revenue climbs 23%, stock dips - Investing.com
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
electroCore Inc Reports Q1 2025 Earnings: EPS Matches Estimates at -$0.47, Revenue Slightly Misses at $6.7 Million - GuruFocus
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
electroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
electroCore Q1 2025 Financial Results: Bioelectronic Leader Hosts Investor Webinar May 7 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
The Future of Vagus Nerve Stimulation Market Growth, Innovations, and Key Trends - newstrail.com
electroCore (NASDAQ:ECOR) Shares Up 14.6% – Here’s What Happened - Defense World
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - The Manila Times
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
(ECOR) Investment Analysis and Advice - news.stocktradersdaily.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Electrocore at 24th Annual Needham Virtual Healthcare Conference: Strategic Expansion Plans - Investing.com Australia
ElectroCore stock hits 52-week low at $5.3 amid challenges - Investing.com
Electrocore Inc (ECOR) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.79%
大文字化:
|
ボリューム (24 時間):